|Submission declined on 26 May 2019 by talk). (|
This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Declined by 3 months ago. Last edited by CommonsDelinker 2 months ago. Reviewer: Inform author.
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (Learn how and when to remove this template message)
NANOLUTE is a medical technology to use to add sirolimus drug layer on stent. Nano carrier based technology, is an excipient based encapsulation method of delivering drug with controlled / mediated release. Drug retention and transfer times can be designed in delivery system.
Drug Eluting Balloons are similar to normal Balloon angioplasty use. They are effective in local drug delivery. No additional training or devices required for its usage. Nenolute is require to mansion sirolimus drug on balloon surface. Also aiming its diffusion and persistence in the vessel all upon inflation. Nanolute provide the right lipophilia to the drug that alone cannot be as lipophilic as paclitaxel.
The following are the advantages of Nanolute:
- Uniform coating surface
- Reduced in-transit loss of drug
- Increased bio-availability of drug
- Better bio-compatibility of drug
- Encapsulation enhances drug retention
- Faster uptake of drug in tissue on delivery
- Drug released on dissolution of naocarrier
- Programmable drug release from surface of device
Choice of Drug
Mechanism of action
the drug from
|Smallest NP will
get absorbed and
|Biggest size NP accum-ed
in intima while middle
size NP will be in
supplies the drug
as a reservoir
|At the end of 28 days,
NP DES will become a
BARE METAL STENT
|STEP 1||STEP 2||STEP 3||STEP 4|